Minerva Medica 2021 February;112(1):114-7

DOI: 10.23736/S0026-4806.20.06727-0

lingua: Inglese

Severe asthma at COVID-19 time: what is new on biologic therapies

Filippo PATRUCCO ^{1, 2} ✉, Elisa VILLA ³, Valentina FOCI ⁴, Alida BENFANTE ⁵, Michela BELLOCCHIA ⁶, Paolo SOLIDORO ^{6, 7}

¹ Division of Respiratory Diseases, Department of Medicine, Maggiore della Carità University Hospital, Novara, Italy; ² Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy; ³ Unit of Pneumology, A.S.L. Genova3, Villa Scassi Hospital, Genoa, Italy; ⁴ Unit U of Pneumology, Department of Medicine, A.S.L. Vercelli, Vercelli, Italy; ⁵ ProMISE Department, University of Palermo, Palermo, Italy; ⁶ Unit U of Pneumology, Department of Cardiovascular and Thoracic Medicine, Città della Salute e della Scienza, University of Turin, Turin, Italy; ⁷ Department of Medical Sciences, University of Turin, Turin, Italy

HTML PDF

inizio pagina

I TUOI DATI

I TUOI ORDINI

CESTINO ACQUISTI

COME ORDINARE

I TUOI ABBONAMENTI

I TUOI ARTICOLI

I TUOI EBOOK

COUPON

ACCESSIBILITÀ

Minerva Medica 2021 February;112(1):114-7

Severe asthma at COVID-19 time: what is new on biologic therapies

Publication History

Per citare questo articolo

Corresponding author e-mail

Share